Granulated mesalamine    (DrugBank: Mesalamine)

1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis2

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,269 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00767728
(ClinicalTrials.gov)
December 200417/9/2008Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative ColitisA Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative ColitisUlcerative ColitisDrug: Granulated mesalamine;Drug: PlaceboBausch Health Americas, Inc.NULLCompleted18 YearsN/AAll256Phase 3United States
2NCT00744016
(ClinicalTrials.gov)
December 200427/8/2008Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative ColitisA Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative ColitisUlcerative ColitisDrug: Granulated mesalamine;Drug: PlaceboBausch Health Americas, Inc.NULLCompleted18 YearsN/AAll305Phase 3United States